Increased Risk of Major Post-Operative Complications in Onco-Geriatric Surgical Patients with an Impaired Nutritional Status. The Preop-Study

2013 ◽  
Vol 4 ◽  
pp. S19-S20 ◽  
Author(s):  
M. Huisman ◽  
R. Audisio ◽  
G. Ugolini ◽  
I. Montroni ◽  
C. Stabilini ◽  
...  
2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 9557-9557
Author(s):  
Monique Huisman ◽  
Barbara Van Leeuwen ◽  
Giampaolo Ugolini ◽  
Isacco Montroni ◽  
Cesare Stabilini ◽  
...  

9557 Background: In the onco-geriatric surgical population it is important to identify patients at increased risk of adverse post-operative outcome in order to effectively implement preventive measures and to improve outcome in this population. There is need for a time saving and efficient screening tool. Our aim was to determine the predictive ability of the Mini Mental State Examination (MMSE), Brief Fatigue Inventory (BFI) and Timed “Up & Go” (TUG) concerning the occurrence of a major post-operative complication in a series of elderly patients undergoing elective surgery for solid tumors. Methods: In an international cohort, 329 patients ≥70years undergoing elective surgery for solid tumors were prospectively included. Primary endpoint was the incidence of a major complication during the first 30 days after surgery. Pre-operatively the MMSE, BFI and TUG were scored. TUG depicts the time needed to stand up from a chair, walk 3 meters, turn around, walk back and sit down. Data were analyzed using multivariable logistic regression analyses to estimate odds ratios (OR) and 95% confidence intervals (95%-CI). Results: The majority of patients underwent major surgery (n=219; 66.6%). A total of 71 (22.1%) patients experienced major complications. TUG, MMSE and BFI, adjusted for center, gender and minor or major surgery, were independent predictors of the occurrence of major post-operative complications (see Table). Conclusions: Screening tools are able to predict major post-operative complications in onco-geriatric surgical patients. TUG is most specific in identifying patients at risk and could be considered to allocate preventive measures effectively. [Table: see text]


Author(s):  
Claire Perkins

Surgical patients are at risk of post-operative complications. A thorough pre-operative assessment and the implementation of appropriate care/treatment plans will reduce the likelihood of complications occurring. The surgical nurse should have a good knowledge and understanding of recognizing, preventing, and treating post-operative complications. The ABCDE approach should be used in the immediate post-operative period and if the patient becomes acutely unwell. This chapter uses body systems and the ABCDE approach to review post-operative complications.


2010 ◽  
Vol 39 (6) ◽  
pp. 758-761 ◽  
Author(s):  
Benedicte Rønning ◽  
Torgeir Bruun Wyller ◽  
Ingebjørg Seljeflot ◽  
Marit Slaaen Jordhøy ◽  
Eva Skovlund ◽  
...  

2019 ◽  
pp. 145749691987758
Author(s):  
S. Maghami ◽  
Y. Cao ◽  
R. Ahl ◽  
E. Detlofsson ◽  
P. Matthiessen ◽  
...  

Background and Aims: Emergency laparotomy is associated with a great risk of mortality in the elderly. The hyperadrenergic state induced by surgical trauma may play an important role in the pathophysiology of this increased risk. Studies have shown that beta-blocker exposure may be associated with decreased morbidity and mortality in the perioperative period. We aimed to study the effect of beta-blocker on mortality in geriatric patients undergoing emergency laparotomy. Material and Methods: This is a retrospective study of patients who underwent emergency laparotomy between 1 January 2015 and 31 December 2016 at a single institution. The outcomes of interest were the association between post-operative complications and in-hospital and 1-year mortality in patients on beta-blocker therapy (BB(+)) and those who were not (BB(−)). The Poisson regression analysis was used to evaluate the association. Results: A total of 192 patients were included of whom 62 (32.2%) had pre-operative beta-blocker therapy with continued exposure during their hospital stay. The in-hospital mortality was 17.7% in the BB(+) and 23.8% in the BB(−) cohorts ( p = 0.441). One-year mortality was significantly lower in the BB(+) group compared to the BB(−) group (30.6% versus 47.7%; p = 0.038). After adjusting for confounders, the incidence of deaths during 1 year post-operatively decreased by 35% in the BB(+) group (incidence rate ratio = 0.65, p = 0.004). No significant differences in the incidence of post-operative complications between the two groups could be measured. Conclusion: Beta-blocker therapy may be associated with reduced 1-year mortality following emergency laparotomy in geriatric patients.


2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii136-ii136
Author(s):  
Ravi Medikonda ◽  
Kisha Patel ◽  
Laura Saleh ◽  
Siddhartha Srivastava ◽  
Christina Jackson ◽  
...  

Abstract Dexamethasone is routinely administered to glioma patients for the management of cerebral edema. Dexamethasone is associated with significant side effects including hyperglycemia, increased risk of infection, and impaired anti-tumor immune response. Despite these risks, there are no standardized guidelines for the effective use of dexamethasone in managing glioma. In this single-institution retrospective cohort study, we evaluate the effect of dexamethasone in glioma patients undergoing surgical resection on post-operative complications and overall survival. 436 patients met the inclusion criteria for this study. 46% of patients received pre-operative dexamethasone, and 90% of patients received post-operative dexamethasone. Pre-operative dexamethasone usage did not significantly affect the immediate post-operative T2 flair volume (p=0.53), however it was associated with a higher incidence of post-operative wound infection (4.0% vs 0%, p=0.002) and post-operative hyperglycemia ((p=0.02). Administration of dexamethasone in the post-operative setting did not affect the incidence of post-operative wound infection (p = 0.38) or hyperglycemia (p=0.18). It also did not affect the 3-month T2 flair volume (p=0.87). On cox proportional hazards analysis, pre-operative dexamethasone was associated with a greater hazard of death (HR=1.48; p=0.01), and post-operative dexamethasone was associated with a lower hazard of death (HR=0.20; p=0.04) after adjusting for several possible confounders. Our findings demonstrate significant differences in the safety and efficacy of pre-operative and post-operative dexamethasone in glioma patients. Routine use of pre-operative dexamethasone appears to increase the risk of post-operative complications and negatively impact survival, whereas post-operative dexamethasone improves survival and was not associated with a higher risk of steroid-related post-operative complications. These findings reaffirm a role for dexamethasone in managing cerebral edema in glioma patients, but also highlight the potential for serious negative consequences with dexamethasone use. This study provides a rationale for re-evaluating the role of dexamethasone, particularly in the pre-operative period.


Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 2370-2370
Author(s):  
Soumitra Tole ◽  
Adam Paul Yan ◽  
Amanda Wagner ◽  
Lissa Bair ◽  
Ken Tang ◽  
...  

Abstract Background: Patients with sickle cell disease (SCD) are more likely to require surgical procedures, and to have post-operative complications compared to the general population. The TAPS trial demonstrated that pre-operative transfusion is associated with a 3.8-fold reduction in peri-operative complications in patients with SCD. Pre-operative exchange transfusion has not been shown to have benefit over simple top-up transfusion. Patients with SCD may have baseline hemoglobin levels higher than the usual 60-80 g/L for a variety of reasons including; non-hemoglobin SS genotype SCD, co-inheritance of deletion(s) in alpha globin genes, hereditary persistence fetal hemoglobin, and hydroxyurea (HU) use. It is less clear whether patients with pre-operative hemoglobin levels > 90 g/L would also benefit from pre-operative transfusions. Previous studies of pre-operative transfusions in SCD have largely not captured these patients, in part due to low HU uptake at the time of the study and exclusion of non-hemoglobin SS SCD. We conducted a retrospective cohort study to assess the role of pre-operative transfusion in patients with SCD and a high baseline hemoglobin. Methods: 1304 patients seen at The Hospital for Sick Children, Toronto between 2007 and 2017 were assessed for eligibility. Patients were included if they: had a baseline hemoglobin ≥ 90 g/L, were 1-18 years of age at the time of surgery, had a diagnosis of hemoglobin SS, SC, Sβ+-thalassemia or Sβ0-thalassemia SCD subtypes, and had a low or medium risk elective surgery under a general anesthetic. Surgeries were classified according to the Co-operative Study of Sickle Cell Disease. Post-operative complications were defined as one or more of the following within 30 days of surgery: fever, vaso-occlusive crisis (VOC), infection, bleeding requiring transfusion, acute chest syndrome (ACS), stroke, intensive care admission (ICU), emergency room visit after discharge, readmission to hospital after discharge, or death. The incidence of postoperative complications for those with a baseline hemoglobin ≥90 g/L was compared between those who received a transfusion and those who did not. To estimate the adjusted effect of pre-operative transfusion on the risk of developing post-operative complications, a multi-variable logistic regression model was fitted using the change-in-estimate procedure, where variables with the strongest influence on the crude (unadjusted) estimate were included as model covariates (i.e. key confounders). Results: 117 patients with a hemoglobin ≥90 g/L underwent a total of 137 procedures. The most frequent procedures included were: tonsillectomies/adenoidectomies (26), cholecystectomies (25), splenectomies (20), and umbilical hernia repairs (11). There were 22 procedures (16%) where a pre-operative transfusion was administered. All patients received simple top-up transfusions. Of these, 11 (50%) encountered at least one post-operative complication. In contrast, 22/115 (19.1%) procedures without a pre-operative transfusion experienced a post-operative complication. There was an increased risk of post-operative complications in the group that was transfused (p=0.003, OR=4.2, 95% CI 1.6-11). Adjusting for two key confounders identified during the modeling process (splenectomy and prior ACS), pre-operative transfusion was again found to be associated with an increased risk of post-operative complications (p=0.017, OR=3.6, 95% CI 1.2-9.2). The characteristics of these patients and the incidence and distribution of post-operative complications are shown in Table 1. Conclusion: Patients with SCD and a baseline hemoglobin ≥90 g/L who receive a pre-operative top-up transfusion have an increased risk of post-operative complications compared to those who are not transfused. In low and medium risk surgeries, a policy of withholding transfusions for such patients may be considered. Prospective studies validating these findings are needed. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document